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 Detection and Mapping of Cannabinoids in single hair samples 
through rapid derivatization - Matrix-Assisted Laser Desorption 
Ionization Mass Spectrometry. 
 
Emma Beasley, Simona Francese and Tom Bassindale*  
Sheffield Hallam University, Centre for Mass spectrometry Imaging-Biomolecular Research Centre, Howard Street, S1 
1WB, Sheffield, United Kingdom  
ABSTRACT: The sample preparation method reported in this work has permitted for the first time the application of Matrix As-
sisted Laser Desorption Ionization Mass Spectrometry Profiling and Imaging (MALDI-MSP and MALDI-MSI) for the detection 
and mapping of cannabinoids in a single hair sample.  MALDI-MSI analysis of hair samples has recently been suggested as an al-
ternative technique to traditional methods of GC-MS and LC-MS due to simpler sample preparation, the ability to detect a narrower 
time frame of drug use and a reduction in sample amount required. However, despite cannabis being the most commonly used illicit 
drug worldwide, a MALDI-MS method for the detection and mapping of cannabinoids in a single hair has not been reported. This is 
probably due to the poor ionization efficiency of the drug and its metabolites and low concentration incorporated into hair. This 
research showed that the in situ derivatization of cannabinoids through addition of an N-methylpyridium group resulted in im-
proved ionization efficiency, permitting both detection and mapping of Δ9-tetrahydrocannabinol (THC), Cannabinol (CBN), can-
nabidiol (CBD) and the metabolites 11-nor-9-carboxy-tetrahydrocannabinol (THC-COOH), 11-Hydroxy-delta-9-
tetrahydrocannabinol (11-OH-THC) and 11-nor-delta(9)-carboxy-tetrahydrocannabinol glucuronide (THC-COO-glu). Additionally, 
for the first time an in-source re-arrangement of THC was observed and characterised in this paper thus contributing to new and 
accurate knowledge in the analysis of this drug by MALDI mass spectrometry. 
The use of hair as an alternative biological sample in toxico-
logical analysis is well documented. This is due to the fact that 
hair offers a longer time frame to detect drug use than the 
more traditional blood or urine. By measuring the length of the 
hair and approximating the rate of hair growth (1 cm a month 
on average) 1, it is possible to estimate when specific drug 
intake occurred, over a time period as long as the length of the 
hair allows (weeks, months, or even years) 2. This is in stark 
contrast to blood and urine analysis where most drugs are not 
able to be detected beyond a few hours to days after intake 3. 
Some important applications of hair samples for 'retrospective' 
detection of drug intake include investigating drug facilitated 
crime, workplace testing, child protection cases, and therapeu-
tic monitoring. 
Hair analysis is often used to identify cannabis consumption. 
Cannabis continues to be the most widely used illicit drug in 
England and Wales, with an estimated 6.7% of adults having 
used cannabis in the last year 4 a higher percentage than the 
European average of 5.7% 5. Δ-9-tetrahydrocannabinol (THC) 
is the main psychoactive constituent of cannabis. THC under-
goes a complex hepatic metabolism based on oxidation and 
subsequent glucuronidation 6. Since this enzymatic pathway is 
only present in vivo, metabolite detection has been suggested 
as a solution to external contamination problems associated 
with solely analysing THC content in hair samples 1. The main 
oxidative metabolites of THC are 11-Hydroxy-delta-9-
tetrahydrocannabinol (11-OH-THC) and 11-nor-9-carboxy-
delta-9-tetrahydrocannbinol (THC-COOH). This molecule 
then undergoes glucuronidation (phase II metabolism) to form 
11-nor-delta(9)-carboxy-tetrahydrocannabinol glucuronide 
(THC-COO-glu) 7 as shown in figure 1. Other cannabinoids 
routinely analysed in hair samples include the Cannabis sativa 
plant degradation products, cannabinol (CBN) and cannabidiol 
(CBD) 8–13.  
Figure 1 Degradation (ex-vivo) and metabolic (in vivo) path-
way of THC 
 
THC and associated cannabinoids and metabolites can already 
be detected in hair samples using standard analytical tech-
niques such GC-MS 12,14–18 and LC-MS 19–23. However, GC-
MS requires multiple laborious and time consuming steps be-
fore chromatographic analysis can take place including diges-
tion, extraction, sample clean-up and derivatization.  
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LC-MS has gained in popularity over recent years as the 
aforementioned derivatization step is often not needed for 
successful analysis. However, both methods require a large 
amount of hair sample (10-50 mg). GC-MS and LC-MS anal-
yses typically give a time of intake accuracy of one month due 
to the common practice of segmenting the hair into 1 cm piec-
es before analysis.  
More recently Direct Analysis in Real Time (DART) has been 
proposed as method for the analysis of cannabinoids and co-
caine in hair samples 2,24, however this method is not able to 
distinguish between the two isobaric species of THC and 
CBD, despite MS/MS analysis due to both compounds result-
ing in the same product ions. In addition to this, a large sample 
size is required and currently the method is only applicable to 
high levels of THC associated with chronic users due to the 
detection limit being approximately 5 ng/mg of hair. The au-
thors stated that DART “should only be considered as a rapid 
pre-screening method”, however, this could result in false 
negative results for lower-level users.  
Matrix Assisted Laser Desorption Ionization-Mass Spectrome-
try (MALDI-MS) has been highlighted as a potential hair 
analysis method due several advantages over current tech-
niques including improved chronological information 25, sim-
pler sample preparation and ability to detect drugs on one sin-
gle hair. Several drugs have already been analysed in hair 
samples using MALDI MSI including methamphetamine 26 
and analogues 27, cocaine 28–31, ketamine 32, Zolpidem 33, and 
nicotine 34 by utilising an α-Cyano-4-hydroxycinnamic acid 
(CHCA) matrix without the need for analyte derivatization. 
Cannabis products were determined in the work of Musshof et 
al 29, but they were unable to determine the difference between 
the isobaric THC and CBD and did not look for any in vivo 
metabolites.     
In this study, initial experiments suggested the occurrence of 
an in source-rearrangement of the THC molecule; in addition 
to low analyte ionization efficiency, this highlighted low prob-
ability of success in mapping cannabinoids in hair samples by 
MALDI MS Imaging (MALDI MSI). However, the final 
method developed included the novel use of 2-Fluoro1-
Methylpyridinium p-tolunesolfonate  (FMTPS) derivatization 
of hair samples in situ and showed greatly improved detection 
of cannabinoids and metabolites, allowing these species to be 
mapped using MALDI-MSI. 
 
EXPERIMENTAL SECTION  
 
Materials and Reagents.  
α-Cyano-4-hydroxycinnamic acid (CHCA), trifluoroacetic 
acid (TFA), 2-Fluoro-1-methylpyridinium-p-toluene-sulfonate 
(FMPTS) and triethylamine (TEA) were purchased from Sig-
ma-Aldrich, UK. Canabinol (CBN), cannabidiol (CBD) Δ9-
tetrahydrocannabinol (THC), 11-nor-9-carboxy-
tetrahydrocannabinol (THC-COOH) 11-Hydroxy-delta-9-
tetrahydrocannabinol (11-OH-THC), delta 9-
tetrahydrocannabinolic acid A (THCA-A) and 11-nor-delta(9)-
carboxy-tetrahydrocannabinol glucuronide (THC-COO-glu) 
were purchased as analytical references from Cerilliant (Sig-
ma-Aldrich, UK) Acetonitrile (ACN) and Methanol were pur-
chased from Fisher Scientific, UK. 
 
Sample preparation. 
CHCA was prepared at 5 mg/mL with the solvent composition 
being 70:30 ACN:0.2% Aqueous TFA.  
Cannabinoid standards were mixed 1:1 with the matrix solu-
tion and deposited in triplicate on the MALDI target. The 
spots were left to dry at ambient temperature before analysis.  
Cannabinoid concentrations were 100 µg/mL. 
  
Derivatization of standards for MALDI profiling analysis. 
Derivatization was carried out according to Thieme et al. 35. 
Briefly, 40µl FMPTS (10 mg/mL in acetonitrile) and 10µl of 
triethylamine were mixed using a vortex. This caused the col-
orless solution to turn "canary yellow" as previously reported 
35,36
. 20µl of each cannabinoid standard (100 µg/mL) was then 
added and left at room temperature for five minutes. 1 µL of 
each solution was then spotted onto a target plate.  
 
Spiking of hair 
Hair samples from an individual who reported not to have 
used any illicit drugs were collected by cutting and washed 
with methanol and water by vortexing.  The samples were then 
cut into 5 cm sections and placed into the bottom of a well in a 
24-well cell culture plate in order to keep the spiking solution 
volume to a minimum whilst still submerging the hairs. The 
limitation of five centimetres is due to the size of a MALDI 
target plate. Spiked samples were prepared by soaking in 300 
µL of 0.5 µg/mL cannabinoid standard solution. Blank hair 
samples were prepared by soaking in 300 µL of methanol. The 
plate was sealed with tape to avoid evaporation of the stand-
ards.  All hairs were soaked for two hours, removed and al-
lowed to dry for one hour at room temperature.  
 
User hair Sample 
The hair sample collection was approved by the Sheffield 
Hallam University Research Ethics committee (SHU ethics 
number 13-2011). The hair sample was provided from a male 
volunteer who self-reported to smoke cannabis once a week.  
The hairs were less than 5 cm in length. To wash, the hairs 
were placed in a clean test tube with methanol (5 mL) and 
briefly vortexed, before being removed. This was repeated 
twice and the hairs were then left for two hours at room tem-
perature to dry. 
 
In situ derivatization of cannabinoids  
The hair was placed on glass slide using double-sided Sello-
tape® Super Clear tape. 2.5 mL of derivatization reagent was 
then sprayed using a Neo for Iwata® air-brush at a pressure of 
30 psi onto an area of 9 cm2 with the sample in the centre of 
the area. This step was carried out in a fume hood due to haz-
ards associated with the use of the tryethylamine catalyst.  
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Deposition of matrix for imaging 
The hairs were coated in CHCA at 5 mg/mL with the solvent 
composition being 70:30 ACN:0.2% Aqueous TFA using the 
SunCollect autospraying system (SunChrom GmbH, Frie-
drichsdorf, Germany). Fifteen layers were sprayed at a flow 
rate of 2 uL/min.  
  
INSTRUMENTATION 
MALDI Instrumentation and analytical conditions  
All data was acquired in positive ion mode on an Applied Bio-
systems/MDS Sciex hybrid quadrupole time-of-flight mass 
spectrometer (Q-Star Pulsar-i) with an orthogonal MALDI ion 
source (Applied Biosystems, Foster City, CA, USA) and a 
Neodymium-doped yttrium aluminium garnet (Nd:YAG) laser 
(355 nm, 1 KHz). The laser power was 30 % (1000 Hz, 3.2 
µJ), which had an elliptical spot size of 100 × 150 µm 37. Im-
age acquisition was performed using the “raster image” mode 
38
. Declustering potential 2 was set at 15 arbitrary units and the 
focusing potential at 20 arbitrary units, with an accumulation 
time of 0.999 sec. The MALDI-MS/MS images were obtained 
using argon as the collision gas; the declustering potential 2 
was set at 15 and the focusing potential at 20, and the collision 
energy and the collision gas pressure were set at 20 and 5 arbi-
trary units, respectively. 
 
Images were acquired using ‘oMALDI Server 5.1’ software 
supplied by MDS Sciex (Concord, Ontario, Canada) and pro-
cessed using Biomap 3.7.5 software (www.maldi-msi.org) to 
generate black and white images for each m/z ratio of interest. 
Further Image analysis and processing was performed using 
the public domain software ImageJ (NIH; 
http://rsb.info.nih.gov/ij); where the previous black and white 
images were assigned different colors and overlaid to create 
one final image.  
 
LC-MS Instrumentation and analytical conditions 
All experiments were performed on a Thermo Finnigan 
LCQ™ ‘classic’ quadrupole ion trap liquid chromatography 
mass spectrometer with electrospray ionization (ESI) inter-
faced to a liquid chromatography system. The system used 
also consisted of an auto sampler and auto injector. The col-
umn used was a Phemonex Lunar® C18 (150 mm x 1mm, 
5μm) with a corresponding guard column. LC-MS/MS Chro-
matographic separation was realised using gradient elution 
according to a previously published method by  Roth et al. 39. 
Briefly, 0.1% HCOOH in water was used as mobile phase A 
and ACN+ 0.1% HCOOH was used as mobile phase B. Mo-
bile phase A was gradually reduced over time whilst mobile 
phase B was increased from 20 to 95%. The total run time was 
15 minutes with the THC molecule eluting at 4 minutes.  
 
RESULTS AND DISCUSSION 
Profiling of THC 
In preliminary MALDI MSP experiments analyses were car-
ried out on the cannabinoid standard THC as purchased from 
the supplier. It was immediately observed a detection issue 
due to interference from matrix ion peak (m/z 315.10 as seen 
in Figure 1A, which is more apparent at concentrations lower 
than 100 µg/mL)  in addition to a general low ionization yield 
in MALDI as previously reported 40. For this reason, different 
matrix systems were trialled including type and amount of 
matrix 2,5-Dihydroxybenzoicacid (DHB), 6-Aza-2-
thiothymine (ATT), 3-Hydroxycoumarin (3-HC) 2’,4’,6’-
Trihydroxyacetophenone monohydrate (THAP), different sol-
vent compositions, different amounts of Trifluoroacetic acid 
(TFA), and the addition of additives (Cetrimonium bromide 
(CTAB), Lithium salts and Aniline). In addition negative 
mode analysis was conducted with 9-Aminoacridine (9-AA) 
matrix. None of these experiments improved the detection of 
THC beyond that achieved with CHCA and will not be dis-
cussed further in this paper. Another observation from these 
MALDI profiling spectra was the presence of the m/z 313.22 
and 315.23 (Fig 1A). While the m/z at 315.23 fitted the ex-
pected monoistopic m/z of THC, the m/z at 313.22 was unex-
plained. However, the lack of the peak at m/z 313.22 in the 
matrix blanks suggests that it is in fact associated with the 
THC molecule.   
 
 
Figure 1. A- m/z region 311-317 of THC standard with CHCA 
matrix. B  Ratio of signal intensity of m/z 313.22 to 315.25 at 
increasing laser energies. 
In order to investigate this phenomenon further, LC-MS-MS 
analysis of the THC standard (100 ug/mL) was carried out. A 
single peak in the chromatogram confirmed the purity of the 
THC standard. Interestingly, the peak at m/z 313.22 was at 3% 
of the intensity of the m/z 315.23 peak (seen on MALDI at 
A 
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approximately 110% (Figure 1A)) and the isotopic peak at m/z 
314.23 was no longer detected. In addition to this, since this 
LC-MS system utilises Electrospray Ionization, it was reason-
able to assume that the additional peak at m/z 313.22 is specif-
ic to the MALDI ionization process and was hypothesised that 
it could be dependent on the laser energy. In fact, experimen-
tally it was observed that increasing laser power causes the 
ratio of m/z 313.22 to 315.23 signal intensity to increase (Fig-
ure 1B). 
One possible explanation for this observation is a laser in-
duced re-arrangement of the THC molecule. The loss of hy-
drogens as free radicals would increase the conjugation of the 
THC molecule, making the molecule more stable and so the 
rearrangement more favourable. MS/MS spectra of the m/z 
313.1 and 315.1 obtained by direct infusion of the  THC 
standard also support this theory; the MS/MS spectra of the 
parent ion at m/z 315.1 is shown in Figure 3A(i) and the 
MS/MS spectra of the re-arranged parent ion at m/z 313.1 is 
shown in Figure 2A(ii). The spectra are very similar with 
many fragments forming from common mass losses (peaks 
labelled with a star) demonstrating that these peaks refer to the 
same (THC) species. Both the parent ions and many of the 
product ions have a mass shift of -2 Th, suggesting the loss of 
two hydrogens from the THC parent ion.  
Bijlsma et al. reported the fragmentation pathway of THC-
COOH including fragments at m/z 193 and m/z 257 based on 
MSE accurate mass data 41. These fragments would be identical 
for THC-COOH and for THC due to the loss of the COOH 
group from the molecule. In this analysis the m/z 259 and 193 
ions were also observed for the 315.1 MSMS, whilst we also 
observed a shift to m/z 257 in the MS/MS spectrum of the 
313.1 parent ion. The 193 fragment was present in both of the 
MSMS spectra, indicating this fragment does not contain the 
proposed site of the rearrangement (See Figure 2B). 
 
 
Figure 2. A. MS/MS spectra of THC. Panel A(i) and A(ii) 
show the Product ion mass spectrum of m/z 315 and of m/z 313 
respectively. Both spectra were obtained through direct infu-
sion on an LCQ instrument. Peaks with a star symbol denote 
a mass shift of 2 Th. Panel B shows the proposed rearrange-
ment of the THC and structures of fragments present at m/z 
259, 257 and 193 (257 and 193 structures as proposed by 
Bijlsma et al.). 
Derivatization of cannabinoids 
Once the nature of the peak at m/z 313.22 was elucidated, in 
order to avoid the rearrangement due to the laser energy a 
chemical modification of THC was carried out. Derivatization 
has previously been identified as a possible strategy to im-
prove signal intensity and decrease matrix interference 42,43. 
The target for the derivatization was the hydroxyl group since 
all cannabinoids of interest contain this functional group. After 
carefully reviewing the literature, the derivatization method 
using 2-Fluoro-1-Methylpyridinium p-tolunesolfonate 
(FMPTS) to form an N-methylpyridinium derivative, as re-
ported by Quirke et al. for the detection of alcohols using elec-
trospray ionization mass spectrometry, was chosen 36. FMPTS 
derivatization has previously been reported to improve the 
detection of a range of compounds with alcohol moieties, in 
various sample types including surfactants 44, oestrogens 45 and 
the narcotic analgesic burprenorphine 35, using LC-MS analy-
sis, and  polyamides 42 and sterols 46 in MALDI profiling ex-
periments.  
This strategy was also selected due to the simplicity of the 
nucleophilic substitution reaction which occurs readily at 
room temperature 47, the stability of the products formed 
44,48
and also the addition of a permanent charge to the analytes. 
This is of particular importance as it allows all cannabinoids to 
be analysed in positive mode analysis (despite the non-
derivatized THC-COOH being theoretically more suited to 
negative mode). 
Derivatization was successful for all cannabinoids of interest, 
with all peaks being observed and in agreement with the ex-
pected monoisotopic m/z values (Table 1). The derivatized 
species show an addition of 92 a.m.u. as first reported by 
Quirke et al. 36 and confirmed by others 45,46.  
 
Table 1- Theoretical and experimental m/z ratios for derivat-
ized and non-derivatized cannabinoid standards.  
After derivatization the ions corresponding to non-derivatized 
cannabinoids were not observed, suggesting that reaction went 
to completion, (or such that non-derivatized cannabinoids re-
Cannabinoid  [M+H] 
Theoretical 
[M+H]  
Experimental  
Derivatized 
[M+92] 
Theoretical 
Derivatized 
[M+92] 
Experimental 
THC 315.23 315.23 406.27 406.28 
CBN  311.20 311.20 402.24 402.24 
CBD 315.23 315.23 406.27 406.28 
11-OH-THC 331.23 331.23 422.27 422.26 
THC-COOH 345.21 345.21 436.25 436.25 
THC-COO-glu 521.24 521.25 612.28 612.28 
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mained present at concentrations below the limit of detection). 
The expected derivatized THC peak at m/z 406.28 was the 
most abundant in the spectrum. However, there was evidence 
that rearrangement still occurred as the peak at m/z 404.27 was 
observed, though it was present at only 6% of the intensity of 
the m/z 406.28 peak, as opposed to approximately 100% when 
run without derivatization. This suggests that the derivatiza-
tion largely protects THC from the re-arrangement, possibly 
due to steric hindrance, or increasing the required amount of 
laser energy to re-arrange the molecule. The peak at m/z 
406.28 was also observed in the mass spectrum of the derivat-
ized CBD molecule. This was anticipated as THC and CBD 
are isobaric species, however an additional peak at m/z 483.32 
was also detected in the CBD spectrum; CBD gains two N-
methyl-pyridinium groups as it has one more hydroxyl group 
than THC. The peak at m/z 483.32 corresponds to the loss of a 
methyl group from the doubly-derivatized molecule expected 
to be observed at m/z 498.32 Theoretically there could be two 
additions of the derivatization group to 11-OH-THC and THC-
COOH and up to five additions on the THC-COO-glu mole-
cule as a result of multiple hydroxyl groups being present, 
though corresponding m/z values were not observed. THC-
COO-glu was detected at m/z 612.28, corresponding to a sin-
gle addition, in the mass spectrum though the peak at m/z 
436.25 was much more abundant, suggesting the glucuronide 
group readily fragments from the parent molecule during anal-
ysis resulting in the detection of the THC-COOH. A further 
experiment increasing the laser power used for analysis 
showed that the ratio of THC-COO-glu to THC-COOH de-
creased with increasing laser power (data not shown). Another 
potential interferent in the assay was THCA-A, the biogenic 
prescursor to THC.  This was analysed using the method and 
showed no trace of the ions relating to THC or derivatised 
THC (data not presented). 
 
It was also noted that for all derivatized samples there was 
almost complete suppression of CHCA matrix-related peaks, 
as previously observed by Murgasova et al. 42. 
 
Imaging of Cannabinoids in hair samples  
Once the detection of cannabinoids through derivatization was 
optimised, this sample preparation method was adapted to 
permit mapping of these species in single hair samples using 
MALDI-MSI. Preliminarily, blank and cannabinoid spiked 
hairs were imaged to verify efficiency of the derivatization 
method for imaging purposes and were compared to hairs 
which had not gone through the derivatization step (Fig 4). 
 
Figure 3. Comparsion between derivatized and non-
derivatized hairs. Hair A soaked in methanol and derivatized. 
Hair B soaked in THC standard then derivatized. Hair C 
soaked in THC-COOH standard and derivatized. Hair D 
soaked in a 1:1 mixture of THC standard and THC-COOH 
standard and derivatized. Hair E soaked in methanol and not 
derivatized. Hair F soaked in THC standard and not derivat-
ized. Hair G soaked in THC-COOH standard and not derivat-
ized. Hair H soaked in a mixture of THC and THC-COOH 
and not derivatized.  
Unless dramatic modifications are made to contrast and 
brightness, underivatized hairs soaked in THC standard could 
not be visualised in the 2D molecular map as the ion signals of 
the underivatized THC were of extremely low intensity. Inter-
estingly THC-COOH could be visualised in the 2-D molecular 
ion map (cyan color) in hairs G and H which were soaked in 
THC-COOH standard and a mixture of THC and THC-COOH 
standard respectively, however this was also at relatively low 
intensity (Figure 4). The peak at m/z 406.2 corresponding to 
derivatized THC is clearly seen in the hair that was spiked 
with THC and subsequently derivatized (red in color). Similar-
ly, the expected ion at m/z 436.2 was observed in the hair 
spiked with THC-COOH and subsequently derivatized (green 
color); the hair which was spiked with a mixture of THC and 
THC-COOH and then derivatized appears yellow in color as 
both THC and THC-COOH ions are present (a mixture of red 
and green gives yellow).  
 
 
Figure 4. Simultaneous imaging of several cannabinoids of 
interest. Hair A soaked in Methanol. Hair B soaked in THC. 
Hair C soaked in CBD. Hair D hair soaked in CBN. Hair E 
hair soaked THC-COOH. Hair F soaked  in 11-OH-THC . 
Hair G soaked in THC-COO-glu. All hairs were derivatized 
with FMTPS prior to analysis.  
1 cm 
1 cm 
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Since it was established that derivatization enhances both the 
THC and THC-COOH signal in imaging experiments (as 
shown in Figure 3), a second mapping experiment with the 
other cannabinoids shown in was carried out (Figure 4). The 
peak at m/z 406.2 corresponding to derivatized THC is clearly 
seen in the hair which was spiked with THC and then derivat-
ized (red m/z map), the peak at m/z 483.2 was observed in the 
hair spiked with CBD and derivatized (yellow m/z map), the 
peak at m/z 402.2 was corresponding to the derivatized CBN 
was observed in the hair which was spiked with CBN and 
derivatized (blue m/z map), the peak at m/z 436.2 correspond-
ing to the derivatized THC-COOH was observed in the hair 
which was spiked with THC-COOH and derivatized (green 
m/z map) and finally the peak at m/z 422.2 corresponding to 
the derivatized 11-OH-THC was observed in the hair which 
was spiked with 11-OH-THC and derivatized (magenta m/z 
map). As with the profiling experiments, THC-COO-glu 
fragmented to give THC-COOH at a m/z of 436.2 (green m/z 
map) and its image intensity reflect a 5X lower concentration 
compared to the other standards due to the concentration in 
which it is supplied. Users' hairs were investigated using the 
derivatization method coupled with MALDI MSI, employing 
this optimised method. In particular, MALDI MS/MS images 
were obtained of hairs collected from a volunteer who self-
reported to use cannabis once a week and the transition m/z 
406.2 derivatized THC parent ion compound to m/z 110.0 was 
monitored (Figure 5). The product ion at m/z 110.0 corre-
sponds to the hydrated methylpyridinium fragment which is 
common to all FTMPS derivatives and has previously been 
used for confirmation [44]. 
 
Figure 5.  MS/MS image of user hairs. 6A shows derivatized 
THC parent ion at m/z 406.2 6B shows the map of the frag-
ment ion at m/z 110.  
 
CONCLUSIONS 
The use of MALDI imaging and profiling to detect canna-
binoids in hair samples following in situ derivatization is pre-
sented. The method shows for the first time potential to detect 
cannabinoids from a single hair.  
During the development of this method an interesting, laser 
induced, THC rearrangement was observed.  This caused in-
creased fragmentation of the THC and hence low ability to 
detect the molecule without derivatization.  The novel in situ 
derivatization, completed in minutes at room temperature us-
ing FMPTS, showed a greatly increased limit of detection over 
the non-derivatized analytes THC, CBD, CBN and THC me-
tabolites.  The ability to detect the metabolites of THC only 
formed in vivo THC-COOH, 11-OH-THC and THC-COO-
Gluc will enhance the ability of the analyst to distinguish be-
tween use and unintentional exposure. During analysis the 
THC-COO-Gluc fragments to form THC-COOH, with the 
consequence that if the m/z 436.2 is detected it cannot be de-
termined which of the analytes was originally present. The m/z 
612 is however unique to the THC-COO-Gluc. This is an ad-
vantage over traditional GC-MS methods where the glucu-
ronide is not generally detected due to the common practice of 
hydrolysis or digestion of the hair sample, which converts it 
into the THC-COOH 49. 
Prior to integration into a toxicology workflow a large sample 
of user hairs should be tested, from different levels of users 
and with different hair types. The comparison of levels of me-
tabolites detected using traditional methods with the results 
from MALDI analysis will determine the limit of detection for 
hair samples and applicability to lower level users as well as 
the possibility of using the method quantitatively in the future. 
This will allow an assessment of the suitability of the method 
for users or whether it will be a screen for external contamina-
tion. The user hair tested here, from a regular but low level 
user, provides proof that the THC at least can be detected.  
The method reported has a sample preparation workflow, not 
withstanding the derivatization step, which is less time con-
suming due to the lack of extraction step, than the traditional 
GC or LC methods. This method also gives the potential to 
simultaneously detect THC and metabolites in a single workup 
and analysis. An additional advantage is the potential of 
MALDI-MSI resolution allowing increased sensitivity to the 
time period of use, better than the traditional month by month 
history, although such an approach will require further valida-
tion. Analysis of hairs from a known cannabis user has shown 
applicability of the method to detect THC in real life samples.   
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